KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • 11/07/2017

    KNCV welcomes G20 leaders Declaration

    The Hague– KNCV Tuberculosis Foundation welcomes the G20 leaders Declaration following the G-20 Summit in Hamburg on the 7th and 8th of…

    Lees meer
  • 27/06/2017

    Baby Steps and Big Victories: Fighting Drug-Resistant TB in Kyrgyzstan

    By Tristan Bayly and Bakyt Myrzaliev. The USAID-funded Challenge TB project is supporting the introduction of shorter regimens and new…

    Lees meer
  • 29/05/2017

    KNCV Annual Report 2016

    The first week in June sees a flurry of activity at KNCV; Challenge-TB is hosting its Country Director’s Meeting, the…

    Lees meer
  • 29/05/2017

    New guidelines can help reduce deafness as a side-effect of DR-TB treatment

    After nearly a year of intense collaboration, KNCV will soon be releasing the new PMDT toolkit for the introduction of…

    Lees meer
  • 26/05/2017

    Dr Tedros Adhanom Ghebreyesus elected Director-General of the World Health Organization

    Addis Ababa, Ethiopia KNCV Tuberculosis Foundation Congratulates Dr. Tedros Adhanom Ghebreyesus for being the new Director-General of the World Health…

    Lees meer
  • 25/05/2017

    Dr. Tedros Adhanom Ghebreyesus, new Director-General of WHO

    KNCV congratulates the new Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, with his election and looks…

    Lees meer
  • 25/05/2017

    KNCV Tuberculosis Foundation says goodbye to Board of Trustees member Dirk Dotinga

    At the annual General Assembly meeting on 10 May 2017, KNCV Tuberculosis Foundation said goodbye to Dirk Dotinga, who served…

    Lees meer
  • Presentations Wolfheze Workshops 2017

    Wednesday 31 May 2017…

    Lees meer
  • 18/05/2017

    Why the Netherlands should step up its ambitions on global health

    On May 18th, representatives of the Dutch government have been invited to attend the G20 discussion on Global Health. In…

    Lees meer
  • 04/05/2017

    Shorter regimens proving effective in Central Asia

    Since January 2017, KNCV has been treating drug resistant TB patients in the Central Asian region as part…

    Lees meer
  • 03/05/2017

    Wolfheze Workshops 2017

    From Wednesday the 31st of May, until the second of June 2017, KNCV is proud to host the eighteenth edition…

    Lees meer
  • 03/05/2017

    Progress in Ethiopia

    On the twelfth of march of this year, over twenty enthusiastic KNCV staff participated in the Annual City-Pier-City marathon in…

    Lees meer
  • 03/05/2017

    Building bridges between the public and private sector in Kazakhstan

    In Almaty, Kazakhstan’s largest metropolis, successful steps are being taken to resolve a persistent national problem; the cavernous divide between…

    Lees meer
  • 03/05/2017

    Engaging private health providers in India

    In the coastal city of Chennai, Southern India, KNCV is actively engaging private healthcare providers with our local partner NGO…

    Lees meer
  • 07/04/2017

    KNCV Tuberculosis Foundation in Vietnam has honorably received the Merit Award

    KNCV Tuberculosis Foundation in Vietnam has honorably received the Merit Award from Vietnam Ministry of Health for its significant contributions…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.